Michael Ostrach Email Address

Chief Financial Officer and Chief Business Officer; Dynavax Technologies Corporation

At Dynavax we are proud of work we do. Through our expertise in TLR biology we have designed compounds that stimulate multiple innate mechanisms of tumor and development of immune memory associated with tumor-specific antigens.

Former CFO, business development and legal affairs executive with over 35 years of experience managing private and public vaccine and immuno-oncology biotechnology companies. Former Board member for two biotechnology companies. Principal functional responsibilities focused on finance and investor relations, strategic and business development and legal and intellectual property. Directly responsible for over $2 billion in public and private financings, partnerships and acquisitions, using an extensive variety of financing vehicles and arrangements.